ASML Stock Falls After Record Q3 2026 Earnings Beat

A record quarter, a falling stock

ASML delivered what by most measures was the best quarter in its history on October 14. Investors sold the shares anyway. The Dutch lithography monopoly reported third-quarter 2026 net sales of €11.7 billion, a record 57.5% gross margin and net income of about €5.0 billion 35. Basic earnings per share came in at €12.95, roughly $14.65. That topped a consensus near $12.13 by about 21% 3.

The market response was negative. One account had the US-listed shares down 1.86% in regular trading and another 2.26% after hours, to about $1,679. That left the stock at a 20-day low, roughly 16% below its 52-week high of $1,999.96 3. Quote data showed a close of $1,650.00 for the session, down 3.94% 1.

What the numbers actually said

The operational story was strong. Management described record sales landing near the top of its guidance range. Margin outperformance came largely from a highly profitable installed base management business, the servicing and upgrading of tools already in customers' fabs 5. Free cash flow reached €11.4 billion, helped by strong orders and down payments, and cash and short-term investments totaled €12.7 billion 5.

Guidance also went up. ASML expects fourth-quarter sales of €14.2 billion to €15.2 billion at a gross margin around 57%. It guided full-year 2026 sales to €44–€45 billion 5. The company also lifted its annual outlook 12. It warned that demand for advanced chipmaking equipment could outstrip its production capacity through 2028 2. On the call, executives framed capacity and execution, not end demand, as the binding constraints 5.

Why the stock fell anyway

Coverage of the sell-off lists a few explanations, and they are not mutually exclusive.

A small revenue miss. Reported revenue of €11.66 billion fell slightly short of analysts' roughly €11.85 billion estimate 2. The gap is modest. But for a company valued on growth, the top line can matter more than an earnings beat.

Lower-quality profit upside. About €500 million of net income came from marking up ASML's investment in Mistral AI 5. That is a non-operating boost. In this analyst's view, it helps explain why a large EPS beat did not translate into enthusiasm. Some of that beat was not driven by selling lithography tools.

Expectations already in the price. The argument made most often is that the result confirmed what a premium valuation had already assumed 3. Options pricing ahead of the report implied a move of about 5.12%, or roughly $34.8 billion in market value. The stock did move, but in the opposite direction from what the profit beat would suggest 1.

Sector-wide selling. Broader pressure on chip stocks also weighed on the shares 2.

Conflicting accounts of the trading

Accounts of the trading day do not line up neatly. One early report said Amsterdam-listed shares were trading higher in the morning after the release 1. Another described US shares dipping only about 0.6% at first, with ASML also posting gains in some markets during the session 2. Later figures show a deeper decline into the close and after hours 13. The likeliest reading is an initial positive reaction that faded as US investors digested the revenue shortfall and the composition of profits. The exact magnitude depends on which listing and timestamp you use.

A pattern across chip leaders

ASML is not the only chip leader to see this reaction. Recent coverage pairs it with TSMC, which reported a 58% jump in profit that beat estimates, yet also saw its stock sink 4. Both companies pointed to sustained AI chip demand. The same piece cites Nvidia's last blowout report, which was also met with selling, as evidence that sky-high expectations now weigh on chipmakers 4.

The takeaway

The fundamentals here are not in question. ASML's order book, margins and guidance all point to continued expansion, and analysts' average price target of about $2,115 sits well above the current price 1. What has changed is the bar. Investors now treat strong results as the baseline for AI-exposed semiconductor names. They punish small blemishes, such as a slim revenue miss or one-off investment gains.

In this analyst's view, ASML's real risk is not demand but supply. If management is right that capacity is the constraint through 2028, the stock's next leg likely depends less on beating estimates. It depends more on proving it can ship enough machines to meet them.